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INTRODUCTION 
 
A “Thrombus” is defined as a blood clot lodged in the blood vessel. When the pathologic 
processes overwhelm the regulatory mechanisms of hemostasis, there is excessive 
formation of thrombin, initiating thrombosis. (1)  The thrombus can cause vascular 
occlusion  
 
Deep venous thrombosis is blood clot in the larger veins. They usually involve the veins 
of the lower limb. Ocasionally, the clot from the lower limb can dislodge and travel along 
the venous system, the heart and get occluded in the pulmonary vasculature. This is 
called pulmonary embolism.  
 
Venous thromboembolism is a term that includes both, deep venous thrombosis and 
pulmonary embolism, which in itself, is a sequele of the former.(2) 
Deep venous thrombosis is defined as formation of a blood clot in the deep venous 
system. A deep venous thrombosis can occur either in the upper limbs or the lower limbs. 
In the lower limbs, the deep venous thrombosis is classified as either proximal, involving 
the femoral vein and distal involving the popliteal veins. The proximal lower limb deep 
venous thrombosis is usually associated with serious chronic diseases such as 
malignancies, biventricular failure and acute respiratory distress; whereas, distal lower 
limb deep venous thrombosis is associated with transient risk factors such as recent 
surgery, immobilization and travel. 
 
Figure 1 Deep venous system of the lower limb 
 
 
 
AIMS AND OBJECTIVES 
 
The aim of the study was to To assess the incidence of deep venous thrombosis and the risk 
factors favouring its development in patients admitted to a medical ward. 
 
Primary Objective: 
The incidence of Deep Vein Thrombosis in patients admitted to a medical ward. 
This study was done in patients getting admitted in C ward under The Department of 
Medicine, Unit 2. 
 
Secondary Objectives: 
To assess the risk factors for development of deep vein thrombosis in patients admitted in 
a medical ward.  
To assess the patient outcomes among patients who are admitted with deep vein thrombosis 
admitted in a medical ward.  
 
 
 
LITERATURE REVIEW 
 
Epidemiology 
 
Global scenario 
The annual incidence of DVT is estimated at 1-3 per 1000 adult population.(3)  A 
community wide survey done in Worcester showed an annual incidence of 48 people in 
100000 population of developing deep venous thrombosis (4). In other studies, the 
incidence of first-time symptomatic VTE directly standardized for age and sex to the 
United States population ranged from 71 to 117 cases per 100,000 population (5). 
 
In one study estimating the proportion of hospitalized patients at risk for deep venous 
thrombosis DVT prophylaxis, it was shown that 36-73% of hospitalized patients all over 
the world, were at risk of developing deep venous thrombosis.  Among the hospitalized 
medically ill patients, 21-71% of patients were at a high risk of developing deep venous 
thrombosis. (6) 
 
Venous thromboembolism is associated with significant contribution to health care cost. 
In 2010, the estimated heath care cost because of hospital acquired venous 
thromboembolism in the United States ranged from 6.8 to 36 billion dollars (7). 
 
According to the Seventh ACCP Conference on Antithrombotic and Thrombolytic 
therapy (8), the absolute risk of development of DVT in hospitalized medical patients 
was 10-20%. Hospitalization for an acute medical illness was independently associated 
with about an eight-fold increased relative risk for venous thromboembolism. It 
accounted for almost a quarter of all venous thromboembolism in the general population.  
Table 1 Absolute risk of DVT in Hospitalized patients 
 
 
 
The Mednox study (9); an international, randomized, double-masked, placebo control 
trial; the role of enoxaparin in preventing thrombosis was evaluated. In the study, 1102 
acutely ill, immobilized general medical patients enrolled. The diagnosis of DVT was 
made based on mandatory lower limb contrast venography, compression ultrasound, 
clinical suspicion of deep vein thrombosis, pulmonary embolism confirmed by 
pulmonary angiography or high-probability lung scan, or, fatal pulmonary embolism. The 
incidence of DVT among the acutely ill medical ward patients was 14.9%. The incidence 
was 5.5% in patients receiving low molecular weight heparin. 
In the Longitudinal investigation of thromboembolism aetiology (LITE) (10), the 
information from two prospective cohort studies, Artherosclerosis Risk in Communities 
(ARIC) and Cardiovascular Health Study (CHS) were combined. The incidence of 
symptomatic deep venous thrombosis and pulmonary embolism in 21,680 patients over 
the age of 45 years was determined. The patients were followed up for a mean duration of 
7.6 years. The age standardized incidence of first-time venous thromboembolism was 
1.92 per 1000 person-years.  The rates were higher in men than women. The incidence 
increased with age. 
According to White et al, among the population of California, the incidence of venous 
thromboembolism was 23 per 100,000 among Caucasians; 29 per 100,000 among African 
Americans; 14 per 100,000 among Hispanics; and 6 per 100,000 among Asian-Pacific 
Islanders.(11)  
 
Scenario in Asia  
Among the Asian population, the incidence of in hospital venous thromboembolism is 
lower than in the Caucasian population. In a study by Gore et al, the prevalence of venous 
thromboembolism was compared between autopsy specimens from Boston, USA and 
Kyushu, Japan. The prevalence of venous thromboembolism was much higher in North 
America (15%) compared to Japan (0.7%) (12) 
The reason for the lower incidence of venous thromboembolism among Asian population 
is not known. It may be related to the lower levels of Factor V Leiden in the Asian 
population (0.5%) compared to American population (5%)   
In the Asian population, a study done in Hong Kong on the Incidence of DVT in 
hospitalized Chinese medical patients (13) reviewed all Doppler ultrasound studies 
performed for deep vein thrombosis for the period from 1 January 2005 to 31 December 
2008. The presence of risk factors, deep venous thrombosis prophylaxis, number of 
patients who developed deep venous thrombosis during hospitalization and readmission 
within 14 days for deep venous thrombosis were looked at. According to the study, the 
incidence of deep venous thrombosis over a period of 4 years was 
 1.8% in 2005 
 2.0% in 2006 
 1.7% in 2007 
 1.1% in 2008 
 
 
 
Table 2 Incidence of DVT in Hong Kong  
 
Indian scenario 
There is no data available on the incidence and prevalence of DVT in the general 
population. The annual incidence of DVT in India is estimated to be at one percent of 
adult population above the age of forty years and 15-20% among hospitalized 
patients.(14) 
 
In India, a prospective study done among medically ill patients in a tertiary hospital in 
North India (15) looked at the  incidence of deep venous thrombosis among medically ill 
hospitalized patients. Consecutive adult patients, more than 18 years of age, admitted to 
the medical wards and ICU at AIIMS New Delhi from July 2006 to July 2008. Venous 
ultrasounds were performed at admission and once after 12+/-8 days of hospitalization. A 
total of 163 patients were screened of which 5 patients developed DVT (3%). The 
incidence rate of DVT calculated was 2.7 per 1000 person-days of hospital stay. 
In the study, the patients who developed DVT, the most frequent underlying disease was 
infectious disease. Two of the patients had pulmonary infection and one had a GIT 
infection. The other underlying illnesses associated with DVT were haematological 
disease and psychiatrical illness. The patients with DVT had a significant higher duration 
of hospital stay.  
 
Table 3 Primary Medical-illness necessitating hospitalization in the study population 
 
 
 
 
 
 Table 4 Demographic profile of patient with DVT in New Delhi 
 
In a retrospective study carried out at Christian Medical College, Vellore, India (16); in-
patient records from January 1996 to December 2005 were analyzed. Deep venous 
thrombosis was diagnosed based on duplex ultrasonography and a diagnosis of 
pulmonary embolism was made based on a combination of CT Angiogram, CQ scan, D-
dimer and ECG. 722 patients were diagnosed to have venous thromboembolism in 
438667 admissions, with an incidence of 17.46 per 10000 admissions. The incidence 
increased over time and stabilized at about 22 per 10000 admissions.  
 
Figure 2 Distribution of venous thromboembolism over time 
 Figure 3 Distribution of venous thromboembolism according to speciality 
 
 
 Risk factors 
 
There are multiple risk factors associated with development of deep venous thrombosis 
and embolism.  
In the MEDNOX study (9), 1102 acutely ill , immobilized general medical patients 
enrolled in the MEDENOX study, multiple logistic regression analysis found the 
following factors to be significantly and independently associated with an increased risk 
for venous thromboembolism. 
 Presence of an acute infectious disease 
 More than 75 years of age 
 History of malignancy 
 Prior history of venous thromboembolism 
 
 
 
 
 
 
 
 
 
 
 Table 5 Incidence of venous thromboembolism by reason of illness 
 
 
Table 6 Potential risk factors for venous thromboembolism 
 
 
 
 
 
Table 7 Relationship between acute medical illness and venous thromboembolism 
 
 
According to the LITE study (10), the conditions associated with venous 
thromboembolism were hospitalization (52%), malignancy (48%), surgery (42%) and 
major trauma (6%). 
Risk factors for hospitalized DVT 
According to the Seventh ACCP Conference on Antithrombotic and Thrombolytic 
therapy (8), the major risk factors for development of venous thromboembolism in 
patients hospitalized with acute medical illness were 
• NYHA class III and IV heart failure 
• COPD exacerbations 
• Sepsis 
• Advanced age 
• Cancer 
• Stroke with lower extremity weakness 
• Bed rest 
 
In a retrospective observational study done in CMC Vellore (16), referred to earlier, 722 
patients with venous thromboembolism was diagnosed in 438667 admissions, the most 
commonly noted risk factors were malignancy (31%), postoperative (30%), other medical 
conditions (21%), haematological conditions (12%) and trauma (4%). 
 
 
 
 
 
 
 
 
 
 
 
Diagnostic modalities 
 
Contrast Venography 
Contrast venography has long been considered the gold standard for diagnosis of deep 
venous thrombosis. In contrast venogram, an intravenous contrast agent is injected in the 
veins and serial radiographs or fluoroscopy is done is to view the contrast flow. It is an 
invasive investigative modality  The validity of using contrast venography for the 
diagnosis of deep venous thrombosis was established in a study (17) that evaluated the 
course of 160 patients suspected clinically of having DVT in whom contrast venography 
was negative. During a six-month follow-up, only 1.3 percent developed DVT (95% CI 
0.4-5.4 percent).  
Contrast venogram is not recommended as an initial screening tool in view of patient 
discomfort and difficulty in obtaining an adequate study. In a report comparing 
impedance plethysmography and ultrasound to venography in 127 hospitalized patients 
with clinically suspected DVT of the lower extremity, venography could not be 
performed in 20 percent of the cases because of contraindications or technical factors 
(18). Hence, contrast venography is not an ideal modality for screening of deep venous 
thrombosis. 
 
 
Impedence Plethymography 
Impedance plethysmography is another investigative modality used for diagnosis of deep 
venous thrombosis. Impedence plethysmography requires the patient to lie still while a 
thigh cuff is inflated. The change in the volume of the blood at the calf is measured by 
the impendence at the calf, determined by electrodes connected around it. Rapid deflation 
of the cuff and the proportional change of impedance over the subsequent three seconds 
is measured. This is used to measure the venous outflow obstruction. Impedance 
plethysmography has a sensitivity of 91% and specificity of 96% for the diagnosis of 
proximal deep venous thrombosis (19). However, impedance plethysmography requires 
special equipment and trained personnel to perform, which are not available in most 
centers.  
Impedance plethysmography is the ideal investigative modality for evaluation of 
recurrent deep venous thrombosis. The impedance plethysmography normalizes at a 
predicatable rate following the occurrence of the first deep venous thrombosis. A repeat 
impedance plethysmography became normal in 67% by 3 months and 92% by 9 months, 
in a series of 161 patients with proven deep venous thrombosis and abnormal impedance 
plethysmography (20). Normalization is less common with compression ultrasound, 
occurring at a rate of 60-70% at one year (21). 
 
 
Compression ultrasound 
The most commonly used investigative modality for the diagnosis of deep venous 
thrombosis is a compression ultrasound. The following features are looked at to make a 
diagnosis of venous thrombosis using compression ultrasound (22,23) 
 Abnormal compressibility of the vein 
 Abnormal Doppler flow 
 The presence of an echogenic band 
 Abnormal change in diameter during Valsalva maneuver 
Prospective studies have demonstrated that the lack of compressibility of a vein with the 
ultrasound probe is highly sensitive (>95%) and specific (>95%) for deep venous 
thrombosis (23,24) 
The limitations of a compression ultrasound are: 
 It is not able to detect isolated thrombi in the iliac vein or that portion of the 
femoral vein within the adductor canal. 
 The results are limited in patients with deformities or a plaster cast. 
 Serial studies need to be performed when the initial test is negative 
 Patients with pelvic neoplasms or abscesses may demonstrate isolated 
noncompressibility of the femoral vein when thrombosis is absent 
 Observer dependent study 
In the event of the initial test being negative serial tests need to be done. Approximately 
2% of the patients with an initial negative screening by ultrasound develop a positive 
study when retested 7 days later. A single repeat study which is negative at the end of 5-7 
days after an initial negative study is predicative of a less than 1% likelihood of venous 
thromboembolism over months of follow up (25,26) 
Doppler sonography is an accurate investigational modality for the diagnosis of deep 
venous thrombosis. In one study of consecutive outpatients with clinically suspected deep 
venous thrombosis, compression ultrasonography had a sensitivity of 100% and 
specificity of 99% (22). In a study of 1290 patients in whom compression ultrasound was 
negative for deep venous thrombosis at presentation and at the end of one week, the 
cumulative rate of venous thromboembolic complications was 0.7 percent at six months. 
This suggested that very few DVTs are missed by compression ultrasonography (27) 
Various studies have looked at physician performed bedside ultrasounds on portable 
devices for diagnosis of deep venous thrombosis. In one study, emergency department 
physicians were given a 10 minute training session on the use of a portable 
ultrasonography apparatus on two points – common femoral vein and popliteal vein. A 
total of 47 physicians performed 199 2-point compression ultrasounds in the emergency 
department. This was compared with the ultrasonographic reports from the tests 
performed by the department of Radiology. The sensitivity was 100% and the specificity 
was 99% (28). 
In another multicenter, retrospective review, a comparison between 128 bedside 
intensivist-performed compression ultrasonographic studies (IP-CUS) with a formal 
vascular study (FVS) performed by ultrasound technicians and interpreted by radiologists 
was done. The physicians received formal training at a three day critical care 
ultrasonography course. Compared with the formal vascular study, it showed a sensitivity 
of 86% and specificity of 96%. The median time between the physician performed 
ultrasound and the formal vascular study was 13.8 hours (29). 
In a meta-analysis of 16 studies involving 2379 patients, the accuracy of emergency 
physician-performed ultrasound (EPPU) for diagnosis of DVT compared with either 
color-flow duplex ultrasound performed by a radiology department or vascular 
laboratory, or to angiography; showed a sensitivity of 96% and specificity of 97% (30). 
 
 
 
 
 
 
 
 
 
 
Relevance of the research topic 
 
Deep venous thrombosis is a globally significant complication associated with 
hospitalization. It is largely preventable by screening for risk factors and prophylaxis.   
There have been a lot of studies on deep vein thrombosis in a medical ward in a medical 
ward in the Asian population and showing a lower incidence compared to the Western 
data. There is a dearth of studies from India on the same.  
 
Very few studies look at both upper and lower limb deep vein thrombosis. In view of the 
current trend of increasing frequency of central venous catheters and peripherally inserted 
central venous catheters, there is a higher chance of developing upper limb deep vein 
thrombosis than anticipated.  
 
In view of the current knowledge and a lack of data from India, it would be relevant to look at 
the incidence of deep venous thrombosis in the Medical Ward and the risk factors associated 
with them. 
 
 
 
 
METHODS 
Study Setting 
This study looked at the incidence of a deep venous thrombosis in a medical ward in a 
tertiary hospital in South India. 
This study was done in Christian Medical College, Vellore, which is a multispeciality, 
tertiary level hospital located in Vellore, Tamil Nadu. In a year there are 19,00,000 
outpatients registrations and 1,20,000 inpatients admissions. In a day; there are 5,500 
outpatients seen, 2,500 inpatients and 30 deliveries conducted.  
The Department of Medicine has 5 units with a total number of 140 beds in the general 
ward and a Medical ICU with 12 beds and Medical HDU with 12 beds. The mean 
duration of hospital stay in the Medical wards is around 6 days. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Total number of patients admitted in the hospital  2014-15 
1,10,132 
 
 
Total number of patients admitted in the Medical Wards   
2014-15 
7976 
 
 
Total number of patients admitted in the C ward   
October 2014 – May15 
7976 
 
 
Patients eligible - 214 
 
 
Patients screened - 43 
 
 
 Study Design 
 
The study done was a prospective, observational study with a cohort design. It aimed to 
look at the incidence and the risk factors for development of a deep venous thrombosis in 
a Medical Ward.  
 
Primary Objective: 
The incidence of Deep Vein Thrombosis in patients admitted to a medical ward. 
This study was done in patients getting admitted in C ward under The Department of 
Medicine, Unit 2. 
 
Secondary Objectives: 
To assess the risk factors for development of deep vein thrombosis in patients admitted in 
a medical ward.  
 
 
 
 Patients 
 
Inclusion criteria: 
We included patients who were 
 Age >18 years 
 Admitted to the Medical Ward under Medicine unit 2  
 Admitted between October 2014 to May 2015 
Exclusion criteria: 
The following subjects were excluded 
 Refusal to give consent 
 Patients admitted with a diagnosis of DVT or pulmonary embolism 
 Patients on therapeutic anticoagulation 
 
 
 
 
 
 
 
 Ultrasound training 
 
The principal investigator was trained in doing Doppler ultrasound for deep venous 
thrombosis by the Department of Radiology for a period of 1 week. Following the 
training the validation of the skills of the principal investigator was performed.  
 
Ultrasound technique: 
 
A bedside ultrasound machine (M-turbo Sononsite, dynamic range – 165dB) was used for 
screening for deep vein thrombosis. The high frequency, vascular probe was used.  
 
Assessment of lower limb DVT: 
Patient made to lie supine. A was present while doing the scan on a female patient. The 
lower limb exposed to visualize the inguinal and the popliteal region. 
To assess for the femoral deep vein thrombosis, the patient’s leg was externally rotated 
and flexed to 30 degrees. The probe was placed in the mid-inguinal point. The foot of the 
probe was held perpendicular to the vessel. The femoral artery was located by with the 
pulsations. This was confirmed with the colour flow. The vein was located medial to the 
artery. This was again confirmed with the colour flow and augmentation.  
To assess for popliteal deep vein thrombosis, the knee was flexed and the hip externally 
rotated. The probe was placed in the posteriomedial aspect of the knee, over the popliteal 
fossa. The foot of the probe was placed perpendicular to the vessel. The popliteal artery 
was located with the pulsations. This was confirmed with the colour flow. The vein was 
located superficial to the artery. This was again confirmed with the colour flow and 
augmentation.  
To assess for axillary deep vein thrombosis, the arm was elevated and abducted to expose 
the axillary region. The probe was placed in the axillary fossa, against the head of 
humerus. The foot of the probe was placed perpendicular to the vessel. The axillary artery 
was located with the pulsations. This was confirmed with the colour flow. The vein was 
located superficial to the artery. This was again confirmed with the colour flow and 
augmentation. Occasionally, there was an anatomical variation where there are two 
axillary veins. This was also looked for. 
To assess for juglar deep vein thrombosis, the neck was turned to the opposite side. The 
probe was placed over the anterior border of the sternocleidomastoid, at the level of the 
crichoid cartilage. The foot of the probe was placed perpendicular to the vessel. The 
common carotid artery was located with the pulsations. This was confirmed with the 
colour flow. The vein was located lateral to the artery. This was again confirmed with the 
colour flow and augmentation.  
 
Diagnosis of a deep venous thrombosis: 
In this study, a compression ultrasound was performed to determine the presence of a 
thrombus. This has shown to have a sensitivity of 100% and specificity of 97% in the 
hands of emergency physicians. (30). The vein is identified and a gradual pressure is 
applied downwards with the transducer. Normally, the vein collapses completely with 
both the walls meeting each other. On removing the pressure, the vein opens again and 
resumes its original shape. The artery does not collapse so easy and is more resilient.  
This compressibility of the vein is indicative of the lack of thrombus in the vein. If the 
vein does not compress at pressures which cause deformation of the artery, it is 
diagnostic of a deep vein thrombosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 Sample size 
 
Assuming an incidence of deep venous thrombosis of 14.9% according to the MEDNOX 
study (9), with a CI of 05% and error of margin of 5%, the sample size calculated was 
196. Assuming an incidence of 15% drop out/loss of data, a sample size of 220 was 
considered. 
The formula used for calculation of the sample size: 
Sample size = [{Z(1-alpha)}
2
xPxQ]/ [D
2
] 
 Z (1-alpha)  -  Confidence interval 
 P   - Prevalence  
 Q   -  [1-P] 
 D  - Precision  
 
Statistical analysis 
Analysis was done using SPSS version 16 (Copyright 2007). Data was entered in  
EPIDATA software with quality control checks such as range and consistency. Data 
quality was further explored using histogram, Box Cox plots and frequency distributions 
(which was used for continuous variables). Categorical variables have been presented as 
numbers and percentages and continuous variables as mean and standard deviation (SD). 
If the distribution was skewed, besides the mean and SD, Median with interquartile range 
have also been presented. Categorical variables were analyzed using Chi square test with 
Yates’s correction and Proportion test. Continuous variables were analyzed using 
Independent sample t test. Non parametric Mann Whitney U test was used when the 
distribution was skewed. Logistic regression analysis was done to determine the risk 
factors for DVT with log link. Model assumptions were checked using likelihood residual 
plots against predicted probability. Goodness of fit of the model was assessed using 
Hosmer Lemeshow chi-square statistics. 
 
Inter-observer reliability 
To assess for the inter-observer reliability and for validation of the skills of the principal 
observer, a reliability exercise was conducted prior to the initiation of the study. This 
exercise was done between the principal observer (self) and Dr. Pavithra Mannam, Asst. 
Professor, Department of Radiology. As the sample size was 196, a total of 40 scans 
(20% of 196 = 39.2)vwere done by both the Radiologist and the principal observer.  Over 
a period of 8 days, 5 scans were done per day in Medicine 2 ward independently by both. 
The observers looked for the presence of deep vein thrombosis with a Doppler ultrasound 
using the compression technique. The data for presence and absence of deep vein 
thrombosis was calculated between both the observers and Cohen’s kappa co-efficient 
was done.  
A kappa value of more than less than 0.4 is a poor inter-observer agreement. A kappa 
value of 0.4-0.75 is fairly good inter-observer agreement. A kappa value of 0.75 is 
suggestive of excellent inter-observer agreement.  
The data from the 40 scans were analyzed for both the observers. The Kappa value for 
the overall presence of DVT was 1.0 with a p value of <0.001, suggestive of excellent 
inter-observer agreement.  
 
Table 8 Kappa’s inter-observer variation  
 
Kappa’s inter-observer variation 
 
 Observer 1  
(Primary investigator) 
Observer 2  
(Radiologist) 
Positive DVT 1 1 
Negative DVT 39 39 
 
 
 
 
  
Table 9 Kappa statistics for inter-observer variability 
 
 
Kappa statistics for inter-observer variability 
    Observer 2 (Radiologist)  Total 
Positive Negative 
Observer 1  
(Primary investigator) 
Positive Count 1 0 1 
% of 
Total 
2.5% 0.0% 2.5% 
Negative Count 0 39 39 
% of 
Total 
0.0% 97.5% 97.5% 
Total Count 1 39 40 
% of 
Total 
2.5% 97.5% 100.0% 
      
Symmetric Measures 
  Value Asymp. 
Std. 
Error(a) 
Approx. 
T(b) 
Approx. 
Sig. 
Measure of Agreement Kappa 1.000 <0.0001 6.325 0.000 
N of Valid Cases 40       
 
 
Data collection 
The study protocol was approved by the Institutional review board (IRB Min. No 8832 
[OBSERVE] dated 07/04/2015). Ethics committee approval was also obtained.   A day 1 
clinical research form was filled. This included demographics as well as known risk 
factors for the development of venous thrombosis. It has been shown that a single repeat 
study that is negative after 7 days predicts a less than 1% incidence of venous thrombus 
(26). Hence the Doppler ultrasonography was performed on 1
st
, 3
rd
, 7
th
, 10
th
, 14
th
, 21
st
, 
and 30
th
 day of hospital admission for included patients. On day 30 or the day of 
discharge (whichever was earlier), the clinical research form was completed with regard 
to the course and complications in the hospital. In the event of the presence of a deep 
venous thrombosis, the treating team was notified. 
The study was done October 2014 to May 2015 in patients admitted in a medical ward 
under Medicine unit 2 at Christian Medical College, Vellore, a tertiary care center in 
South India. 
The primary outcome looked at was the incidence of development of a deep venous 
thrombosis in patients admitted in a medical ward using a four point compression 
ultrasound. A diagnosis of DVT (Deep venous thrombosis) was made if there was non-
compressibility using a four point Doppler ultrasound on Day 1, Day 3, Day 7, Day 10, 
Day 14, Day 21, and Day 30 of hospital admission.  
 
The various exposures looked at were: 
 Age 
 Sex 
 Previous history of venous thromboembolism  
 Whether on any anticoagulation 
 Past or present history of malignancy 
 Stroke 
 History of trauma 
 History of surgery 
 Central venous catheters  
 Dialysis 
 Acute respiratory distress 
 Congestive cardiac failure 
 Hypercoagulable states 
 Hormone therapy 
 COPD 
 Varicose veins 
 Mobility status 
 
 
 
 
 
 
RESULTS 
Inclusion of patients: 
There were a total of 1,10,132 admissions in Christian Medical College Vellore in the 
year 2014-2015. There were a total of 7976 patients who got admitted in Medical wards 
in the year 2014-2015. During the study period, there were a total of 737 patients who 
were admitted to the ward. Of these patients 214, were eligible and 43 were screened for 
the study. 
 
 
 
 
 
 
 
 
 
 
 
 
Total number of patients admitted in the hospital  2014-15 
1,10,132 
 
 
Total number of patients admitted in the Medical Wards   
2014-15 
7976 
 
 
Total number of patients admitted in the C ward   
October 2014 – May15 
7976 
 
 Patients eligible - 214 
 
 Patients screened - 43 
 
 Patients with DVT - 3 
 
 
 Baseline characteristics  
 
Table 10 Baseline characteristics – At the time of admission 
Baseline characeteristics – At admission  
VARIABLE  FREQUENCY (N=43) 
Age in years, Mean (SD) 47 (18.25) 
Male, n (%) 22 (51.2) 
Malignancy, n (%) 2 (4.7) 
Past history of surgery (<3 weeks), n (%) 2 (4.7) 
Past history of DVT, n (%) 0 (0) 
Past history of Pulmonary embolism, n 
(%) 
0 (0) 
Smoking, n (%) 9 (20.9) 
Bed bound, n (%) 22 (51.2) 
Cerebrovascular accident, n (%) 5 (11.6) 
Heart disease, n (%) 6 (14) 
 The mean age of the patients was 47 years with a standard deviation of 18.25. There was 
equal male and female predisposition with 51.2% of the population being male. 
 
Figure 4 Gender 
 
Out of the 43 patients being studied, 2 (4%) had history of malignancy, 2 (4.7%) had 
history of surgery in the preceding 3 weeks. The history of smoking was present in 9 
(20.9%) of the patients. There were 22 (51.2%) of the patients who were bedbound and 
dependent on their caretakers for the activities of daily living.  There were 5 (11.6%) 
patients who had cerebrovascular accident and 6 (14%) of patients who had history of 
heart disease.  
 
Male 
51% 
Female 
49% 
Gender 
Table 11 Baseline characteristics – In hospital  
Baseline characteristics  - in hospital  
VARIABLE FREQUENCY (N-43) 
Central venous catheter, n (%) 3 (7) 
Dialysis, n (%) 0 (0) 
ARDS, n (%) 2 (4.7) 
Well’s score,  
Median (range)  
1.5 (6) 
DVT Prophylaxis, n (%) 12 (27.9) 
Duration of hospital stay, median 
(range) 
6 (37) 
 
Of the patients studied 3 (7%) of the patients had central venous catheter insertion. None 
of the patients had past history of DVT or Pulmonary embolism. None of the patients had 
dialysis. The median duration of hospital stay was 6 days with a range of 37.  
 There were 12 patients on DVT prophylaxis constituting 27.9% of the population. 
Among the 12 patients, 1 (8.3%) were on TED stockings and 11 (91.7%) were on 
Heparin prophylaxis. The median Well’s score was 1.5 with a range of 6. 
 Figure 5 Baseline characteristics 
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Primary Outcome 
Among the 43 patients screened for deep vein thrombosis in a Medical ward from 
October 2014 to May 2015, there were 3 patients who developed deep vein thrombosis 
(6.98%). The incidence of deep vein thrombosis among the patients admitted in a 
Medical ward was 7.48 per 1000 patient days.  
Table 12 Primary outcome 
Primary outcome  
Total number of patients screened 43 
Total number of positive DVT 3 
Percentage of patients who developed DVT 6.98% 
Cumulative duration of hospital stay 401 days 
Incidence of DVT 7.48 per 1000 patient days 
 
 
Of the patients who developed deep vein thrombosis, 2 (66.6%) had a deep vein 
thrombosis in the femoral vein and 1 (33.3%) in the axillary vein.  
 
Figure 6 Site of DVT 
 
The patient with the axillary vein thrombosis, developed the deep vein thrombosis 
secondary to a central venous catheter. She was diagnosed to have cryptococcal 
meningitis and refractory shock. The central venous catheter was inserted for intravenous 
antifungal therapy and for shock. She succumbed to her illness. 
The two patients with femoral vein thrombosis did not have any central venous catheter 
done. The treating team was informed about the presence of the deep vein thrombosis and 
further appropriate therapy was initiated. 
33% 
67% 
0% 0% 
Site of DVT 
Axillary Jugular Femoral Popliteal 
Secondary outcomes 
The secondary outcome of the study was to look at the risk factors to development of 
deep vein thrombosis in the patients admitted in a medical ward. A univariate analysis 
was done among patients screened. 
Table 13 Univariate analysis – part 1 
Univariate analysis – Part 1  
VARIABLE DVT present 
(N-3) 
DVT absent 
(N-40) 
P value 
Age >50 years,  
n (%) 
2 (9.5) 19 (90.3) 0.607 
Male,   
n (%)  
2 (66) 20 0.578 
Malignancy,  
n (%) 
0 2 0.692 
Surgery (<3weeks) 
n (%)  
1 1 0.014 
Past history of 
DVT,  
n (%) 
0 0  
Past history of PE,  
n (%) 
0 0  
Smoking,  
n (%) 
1 8 0.584 
Bed bound  
n (%) 
2 20 0.578 
Cerebrovascular 
accident,  
n (%) 
0 5 0.515 
 
 
Table 14 Univariate analysis – part 2 
 
Univariate analysis – Part 2 
VARIABLE DVT present 
(N-3) 
DVT absent 
(N-40) 
P value 
Heart disease,  
n (%) 
0 6 0.470 
Central venous 
catheter,  
n (%) 
1 2 0.063 
Thrombophlebitis,  
n (%) 
0 1 0.782 
Hypercoagulable 
state,  
n (%) 
0 3 0.623 
Dialysis,  
n (%) 
0 0  
ARDS,  
n (%) 
0 2 0.692 
DVT Prophylaxis,  
n (%) 
2 10 0.121 
Well’s score  
Median (range) 
6 (1.5) 1.5 (6) 0.008 
Hospital stay 
>7days,  
n (%)  
3 (16.7) 15 (83.3) 0.066 
Age 
The mean age of the patients in this study was 47 years. A univariate analysis was done 
with age more than 50 years and patients with age less than 50 years.  Among patients 
more than 50 years of age, 2 (9.5%) developed DVT and 19 (90.3%) did not develop 
DVT. The Odds ratio was 2.2 (C.I: 0.2-26.4). The p-value was 0.607. Age was not a 
significant risk factor for development of in-hospital deep venous thrombosis.  
 
Figure 7 Age >50 years developing DVT 
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Gender 
There were 22 males (51.2%) and 21 females (49.8%) evaluated in this study. A 
univariate analysis was done among males and females. Among the males 2 (9%) 
developed deep vein thrombosis and 20 (91%) did not develop deep vein thrombosis. The 
odds ratio was 2 (C.I: 0.2-23.9). The p-value was 0.578. Age was not a risk factor for 
development of deep vein thrombosis.  
 
Figure 8 Gender 
 
Malignancy 
In this study, 2 patients had malignancy, but none of them developed deep vein 
thrombosis.  
2 1 
20 20 
Males Females 
Gender 
DVT present No DVT 
 Surgery in the past 3 weeks 
There were 2 patients who had history of surgery in the preceding 3 weeks prior to 
admission. 1 patient developed DVT and 1 patient did not develop DVT. The Odds ratio 
was 19.5 (C.I: 0.87 – 439.3). The p-value was 0.014. Surgery in the preceding three 
weeks was a risk factor for development of deep vein thrombosis.  
 
Figure 9 Surgery in the preceding 3 weeks 
 
Smoking 
There were 9 patients who had history of beedi/cigarette smoking. Among the 9 patients, 
1 (11.1%) developed deep vein thrombosis and 8 (88.9%) did not develop DVT. The 
33% 
67% 
Surgery in the preceding 3 weeks in patients 
with DVT positive 
Surgery in the preceding 3 weeks No surgery 
Odds ratio was 2 (C.I: 0.16-24.9). The p-value was 0.584. Smoking was not found to be a 
risk factor for development of deep vein thrombosis.  
 
Figure 10 Smoking 
 
Bed bound 
Among the patients screened, 22 patients were bed bound. Of the bed bound patients, 2 
(9%) developed deep vein thrombosis and 20 (90.9%) did not develop dep vein 
thrombosis. The Odds ratio was 2 (C.I: 0.17-23.9). The p-value was 0.578. Being bed 
bound was not found to be a risk factor for development of deep vein thrombosis.  
11% 
89% 
Smoking 
DVT positive DVT Negative 
 Figure 11 Bed bound state 
 
Cerebrovascular accident 
In this study, 5 patients had cerebrovascular accident, but none of them developed deep 
vein thrombosis.  
 
Heart disease 
In this study, 6 patients had had history of heart disease, but none of them developed deep 
vein thrombosis.  
 
9% 
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Hypercoagulable state 
In this study, 3 patients had hypercoagulable state.  One patient had polycythemia, one 
patient had pregnancy and another patient had a haematological malignancy. None of the 
patients with hypercoagulable state developed deep vein thrombosis.  
 
Acute respiratory distress syndrome 
In this study, 2 patients had acute respiratory distress syndrome. None of the patients with 
acute respiratory distress syndrome developed deep vein thrombosis.  
 
Central venous catheter 
In this study, 3 patients had central venous catheters. Among the patients with central 
venous catheter, 1 (33.3%) developed deep vein thrombosis and 2 (66.7%), did not 
develop deep vein thrombosis. The Odds ratio was 9.5 (C.I: 0.58-154.7). The p-value was 
0.063. Central venous catheter was a risk factor for development of deep vein thrombosis.  
  Figure 12 Central venous catheter 
 
Hospital stay 
The median duration of hospital stay was 6 days. The patients were divided into hospital 
stay more than 7 days and less than 7 days. Among patients who had a hospital stay of 
more than 7 days, 3 (16.7%) had deep vein thrombosis and 15 (83.3%) did not have deep 
vein thrombosis. The relative risk was 1.2 (C.I: 0.98-1.5). The p-value was 0.066. The 
development of deep vein thrombosis was associated with a higher duration of hospital 
stay.  
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Well’s score 
The median Well’s score in the patients who had deep vein thrombosis was 6 with a 
range of 1.5. The median Well’s score in the patients without deep vein thrombosis was 
1.5 with a range of 6. The p-value was 0.008 which was statistically significant. 
 
 
Multivariate analysis 
 
Among the univariate analysis, the factors which were significant for development of 
deep vein thrombosis in patients admitted to a medical ward were 
1) Surgery in the preceding 3 weeks 
2) Central venous catheter 
3) Duration of hospital stay 
4) Well’s score 
Multivariate analysis and logistical regression was applied for assessment of independent 
risk factors.  
 
 
 
 
Table 15 Multivariate analysis 
Multivariate analysis 
Variable Odds ratio 95% C.I. p-value 
Surgery <3 weeks 2.4 0.38-488 0.120 
Central venous 
catheter 
0.4 0.049-433 0.509 
Well’s score 0.290 0.047-1.772 0.180 
Duration of 
hospital stay 
4.7 1.02-1.3 0.029 
 
 
In the multivariate analysis, surgery in the preceding 3 weeks and central venous catheter 
insertion were not statistically significant as an independent risk factor for development 
of deep vein thrombosis. The duration of hospital stay was statistically significant 
suggestive of a longer hospital stay for patients with deep vein thrombosis. 
 
 
 
  
Patient outcomes 
Another secondary outcome looked at in this study was the patient outcomes. The 
variables looked at were mortality and duration of hospital stay.  
Death 
In the 43 patients studied, 5 patients had in-hospital death and 3 patients were discharged 
against medical advice. In the 3 patients who developed deep vein thrombosis in hospital, 
1(33%) patient had in-hospital death and 2 (66.7%) patients were discharged in a stable 
condition.  In the patients who did not develop deep vein thrombosis 4 (10%) patients had 
in hospital death, 3 (7.5%) were discharged against medical advice and 33 (82.5%) 
patients were discharged in a stable condition. The p-value for mortality was 0.445. There 
was no statistical difference in mortality among patients with DVT and without DVT. 
 
Figure 13 Patient outcomes - mortality 
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 The mean duration of hospital stay was 9 days. The median duration of hospital stay was 
6 days, with a range of 2 – 39 days. The mean duration of hospital stay for patients who 
developed deep vein thrombosis was 27.33 days. The median duration of hospital stay for 
patients who developed deep vein thrombosis was 25 days. The mean duration of hospital 
stay for patients who did not develop deep vein thrombosis was 7.98 days. The median 
duration of hospital stay for patients who did not develop deep vein thrombosis was 5.5 
days. 
 
Figure 14 Duration of hospital stay 
27.33 
7.98 
25 
5.5 
DVT present DVT absent 
Patient outcome - duration of hospital stay 
Mean duration of hospital stay Median duration of hospital stay 
DISCUSSION 
Incidence of DVT in a medical ward 
In our medical ward, among the patients screened 6.98 % developed deep vein 
thrombosis.  The incidence of deep vein thrombosis in our medical ward was found to be 
7.48 per 1000 patient years. Every 125 days of hospital stay was associated with one deep 
vein thrombosis event.  
 
Comparison with Indian data 
In a study done in patients admitted to ICU and wards AIIMS, New Delhi, 3% of the 
patients developed DVT with an incidence of 2.7 per 1000 patient-days. The incidence in 
our study was higher at 7.48 per 1000 patient-days. The higher incidence could be 
attributed to higher percentage of patients being immobilized and more frequent DVT 
screening in our study. 
 
Comparison with Asian data 
The incidence of deep vein thrombosis in a study done in Hong Kong (13) in a study 
done among Chinese patients was 1.1%. The incidence in our study was higher than seen 
in Asian data.  
 
 Comparison with global data 
The incidence of deep vein thrombosis according to the MEDNOX study (9), was 14.9%. 
According to the 7
th
 ACCP conference on Antithrombotic and Thrombolytic therapy (8), 
the absolute risk of development of deep vein thrombosis was 10-20%.  The percentage 
of patients developing deep vein thrombosis in our study (6.98%) was lower than the 
incidence seen in the West.  
 
Risk factors for deep vein thrombosis 
 
One third of the deep vein thrombosis was secondary to a central venous catheter 
insertion. The incidence of deep vein thrombosis was higher in males than females, but 
the difference was not statistically significant. Among patients more than 50 years of age, 
the incidence of deep vein thrombosis was higher, but the difference was not statistically 
significant. Patients who had history of surgery in the preceding 3 weeks had a higher 
risk of developing deep vein thrombosis with an odd’s ratio of 19.5.  
The incidence of deep vein thrombosis was higher in patients who were smokers, but the 
result was not statistically significant. Bed bound state was not statistically significant for 
development of deep vein thrombosis. None of the patients screened with heart disease or 
cerebrovascular accident developed deep vein thrombosis. This was probably due to DVT 
prophylaxis prescribed to patients with cerebrovascular accident and initiation of 
anticoagulation in patients with heart disease.  
None of the patients with hypercoagulable states developed deep vein thrombosis. This 
was possibly due to initiation of anticoagulation and DVT prophylaxis in patients 
admitted with known hypercoagulable state.  
Among the patients who had central venous catheters inserted during the hospital stay, 
had a higher incidence of deep vein thrombosis with a odds ratio of 9.5. Out of the 3 
patients who developed deep vein thrombosis in this study, 1 patient developed a central 
line related deep vein thrombosis of the axillary vein. In a study done in 2015 (31), 
femoral central venous lines had the highest incidence of symptomatic deep vein 
thrombosis (1.4%) in comparison to subclavian (0.5%) and jugular lines (0.9%). In our 
study, we had one patient who developed an axillary vein thrombosis (33%) 
 
Patient outcomes 
Duration of hospital stay 
It was noted in this study that the duration of hospital stay was much higher in patients 
who developed deep vein thrombosis. Development of deep vein thrombosis was 
associated with more than four times increase in the duration of hospital stay. The median 
duration of hospital stay for patients without DVT was 6 days compared to 25 days in 
patients who developed DVT. A higher duration of hospital stay is associated with higher 
risks for the patient including increased exposure to hospital pathogens and infectious 
agents, complications of anticoagulation and treatment for deep vein thrombosis, higher 
financial burden and increased duration of follow up after discharge.  
 
Mortality 
The mortality rate in patients who developed deep vein thrombosis was 66% compared to 
10% in the patients who did not develop deep vein thrombosis. However, this difference 
was not statistically significant with a p-value of 0.445.  
 
 
 
 
 
 
 
 
 
 
 LIMITATIONS 
The significant limitation of this study was the number of patients studied. The sample 
size calculated was 220 and 214 patients were recruited, out of which 43 patients 
consented for the research. The small number of patients would affect the results of the 
study.  
The study was planned to be done on consecutive patients admitted in the ward, but in 
view of personal constrains and mechanical issues with the ultrasound machine, was not 
complete. In this study, as far as possible, consecutive patients were tried to be recruited.  
 
 
 
 
 
 
 
 
CONCLUSIONS 
 
 The incidence of deep vein thrombosis among patients admitted in a medical ward 
in a tertiary care hospital in South India was 7.48 per 1000 person-days. 
 
 Hospital admission of more than 7 days was found  to be significant independent 
risk factor for development of deep vein thrombosis in our study 
 
 Deep vein thrombosis prophylaxis should be considered in patients with hospital 
stay of more than 7 days. 
 
 Further studies need to be done to devise strategies to reduce the development of 
deep vein thrombosis in these high risk groups. 
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 ANNEXURE – 1 – Clinical Reseasrch Form 
 
 
 
DVT IN MEDICAL WARDS 
Clinical Research Form 
 
 
PART 1 
 
Serial Number : 
Name   : 
Hospital Number : 
Age :            Gender : 
Occupation  : 
 
 
 
Malignancy Surgery < 6 weeks Past DVT 
Past PE Smoking Bed Bound 
CVA OCPs Varicose Veins 
 
 History of heart disease    : Yes   No 
 - If yes, for how long  : 
 - Type of heart disease : 
 - NYHA class   : 
 
  
 
 
PART 2 
 
 DAY  
1 
DAY  
3 
DAY  
7 
DAY  
10 
DAY 
14 
DAY  
21 
DAY  
30 
LEFT 
UPPER 
LIMB 
       
RIGHT 
UPPER 
LIMB 
       
LEFT 
LOWER 
LIMB 
       
RIGHT 
LOWER 
LIMB 
       
 
 
 
 
 
 
 
 
 
 
PART 3: 
 Diagnosis      : 
 Central venous catheters inserted : Yes   No 
 Thrombophlebitis  : Yes  No 
 Mobility status 
 Level 1 : (total bed rest or sedentary patient) 
 Level 2 : (level 1 with bathroom privileges) 
 Level 3 : (level 2 with activity as tolerated by the patient) 
 Hypercoagulable state   : Yes  No 
 
 Dialysis     : Yes  No 
 ARDS      : Yes   No 
 On DVT prophylaxis    : Yes  No 
 If yes, prophylaxis modality used : 
 Diagnosed DVT/Pulmonary embolism : Yes  No    
 Duration of hospital stay   : 
 Death 
 
  
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE 2 - CONSENT FORM  
 
 
Study title: DVT in Medical wards  
 
Study pattern: Observational Study  
 
Place of Study: C Ward. Christian Medical College, Vellore 
 
Name of the Principal Investigator: Dr. Audrin Lenin, PG Registrar, Department of 
General Medicine 
 
Name of the Guide: Dr. JV Peter, Professor, Department of Medicine 
 
Approximate Number of Subjects: 220 
 
Information sheet 
 
Introduction:You are invited to take part in this research study to study if your illness is 
in any way contributing to the development of blood clots in your lets or your lungs. It is 
not clear if medical illness, such as what you have, may increase your risk of developing 
blood clots and this study will look at this aspect.  
Purpose of the research: A “thrombus” is a clot in the blood vessel which usually 
occurs due to three factors – alterations in flow of blood, increased tendency of the blood 
to clot, and injury to the blood vessel wall. Deep venous thrombus refers to a clot in the 
deep veins of the body. It is of concern because it can break off and lead to pulmonary 
embolism (clot in the pulmonary vessels) and in turn death if not identified and treated.  
Deep venous thrombosis is a common problem in hospitalized patients, especially in 
patients of intensive care. Numerous studies pointing towards the occurrence of deep 
venous thrombosis in medical wards despite measures to prevent the same, and limited 
studies on deep venous thrombosis in an Indian demographic, led us thinking on the lines 
of this topic, which necessitated a detailed evaluation and therefore shaping into this 
research paper. 
Participant selection: You are being requested to participate/allow your relative to 
participate in this study as you/he/she have/has been admitted in *C Ward under 
Medicine Unit 2. The expected duration of the requested participation in this study would 
be 7 days from the time of admission into the ward, i.e., from the time of entering the 
study. In case you are discharged prior to that, we would only collect the information till 
the day you are admitted in hospital. 
 
Voluntary participation: Your participation in this research is entirely voluntary. It is 
your choice whether to participate or not. Whether you choose to participate or not, the 
management and standard of care will remain the same. If you choose not to participate 
in this research project, you will still continue to receive the same standards of treatment.  
You may change your mind later and stop participating even if you agreed earlier. This 
will in no way affect the care that we provide to you. 
Information on the research-Procedures & Protocol: We will perform scans 
(ultrasound scans) on the legs on Days 1, 3 and 7 to look for the presence of clots. Apart 
from this we will collect some information on the disease that you suffer from, details of 
treatment as well as test results to correlate. The scan itself is painless and does not cause 
any side-effects.  
Appropriate Alternate Procedures:  Other tests are available for detecting blood clots 
are more complex scans and tests like venogram (where a dye is injected into the leg and 
X-rays are taken to assess for clots). However although they may give more information 
they are more painful and can pose a small risk of developing allergy to the dye that is 
injected. If you need this test for further evaluation, we will talk to you about it. 
Risks: There is a very minimal risk of dislodgement of a clot while doing the Doppler 
ultrasonography. 
 
Benefits: The potential benefit is that these scans are not routinely done in patients 
admitted to the medical wards. If we do find a clot in the leg, we will inform your treating 
doctors regarding it. 
 
Reimbursements: You will not be charged for the cost of scan. There are no other 
incentives. You will not be paid for your participation in the study. 
 
Confidentiality: We will ensure confidentiality of your name and no information that 
identifies you will be present once we analyze the information and send it for publication. 
 
Sharing of the result: The result of this research is a property of Christian Medical 
College, Vellore; and I am entitled to publish it in a journal or present it in a conference. 
The participant will have no claim towards the same. 
 
Right to Refuse or Withdraw: You do not have to take part in this research if you do 
not wish to do so. You may also withdraw participating in the research after giving the 
consent. It is your choice and all of your rights will be respected. 
This proposal has been reviewed and approved by the research and ethics committee of 
the hospital whose task it is to make sure that research participants are protected from 
harm.  If you wish to find about more about the IRB, contact 
 
 
Research Office, 
second floor, 
Carman block,  
Christian Medical College,  
Bagayam, Vellore 632002.  
Email:research@cmcvellore.ac.in 
telephone: 04162284294.  
 
It has also been reviewed by the Ethics Review Committee CMC Vellore, which is 
supporting the study.  
If there are any further queries regarding this study or regarding the rights of the 
participants, you can contact me at 
Dr. Audrin Lenin 
PG Registrar, 
Department of General Medicine, 
Christian Medical College, Vellore. 
Ph.No.: 9715916451  
 *  Ward – C ward under Medicine Unit 2 
** DVT – Deep Venous Thrombosis 
@ Me/I – Principal Investigator 
#  You – Subject/Participant 
 
Date: 
 
 
 
 
 
 
 
 
 
 
 
  
 
II.Certificate of Consent 
 
Study Title: Determination of Incidence and Risk Factors of Deep Venous Thrombosis in 
a Medical Ward 
 
Subject’s Name: ________ 
Date of Birth / Age:_______ 
 
Please tick the boxes: 
 
(i) I confirm that I have read and understood the information sheet dated _________ for 
the above study and have had the opportunity to ask questions. [ ] 
 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
 
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further research 
that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
access. However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ] 
 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
 
 
 
 
 
ANNEXURE -3 IRB Protocol 
APPLICATION FOR IRB APPROVAL OF OBSERVATIONAL 
(CASE-CONTROL / COHORT/ CROSS-SECTIONAL) STUDIES 
 
CHRISTIAN MEDICAL COLLEGE, VELLORE 
(Please complete Sections I to III and submit with all supporting documents) 
 
SECTION I 
 
Fluid Research Funding/External Funding 
 
If for external funding, please provide name of funding agency and the 
application for submission in the funding agency’s format, in addition to this 
application. 
 
 
1. Title of Research: Incidence and risk factors of deep venous thrombosis among 
patients admitted to a medical ward at a tertiary hospital in South India. 
 
2. Title of Study (for lay public) : Deep Venous Thrombosis in a medical ward 
 
 
3. Acronym if any :  DVUS-M 
 
4. Unique Protocol ID, if any 
 
5. Name of the Principal Investigator:  
Audrin Lenin 
Department of Medicine 
Christian Medical College, Vellore 
Vellore, Tamil Nadu 
632004 
 
If Post Graduate Registrar / Fellowship: Post graduate registrar 
Enrollment date of PG Course:  06/2013 
Completion date of PG Course: 05/2016 
 
6.    Name of Guide (for Post-Graduate Registrar / Fellowship): 
Dr. John Victor Peter 
Professor 
Department of Critical Care 
Christian Medical College, Vellore 
 
 7.    Name and Designation of Co-Investigator(s), Employment Number and Address  
       Dr. Thambu David 
 Professor and Head 
 Medicine Unit 2 
 Christian Medical College, Vellore 
  
 Dr. Sudha Jasmine 
 Associate Professor 
 Medicine Unit 2 
 Christian Medical College, Vellore 
 
 
 
 Dr. Ravikar Ralph 
 Assistant professor 
 Department of Medicine 
 Christian Medical College, Vellore 
  Dr. Nathaniel Samson Devakiruba 
 Assistant professor 
 Department of Medicine 
 Christian Medical College, Vellore 
 
 Dr. Pavithra Mannam 
 Assistant Professor 
 Department of Radiology 
 Christian Medical College, Vellore 
 
8. Department of Institution where the research will be carried out 
Christian Medical College, Vellore 
 
9. Names and addresses of other institutions where research will be carried out 
-nil- 
 
10. Duration of the Scheme. 
2 years 
  
11. Source/s of Monetary or Material Support 
Internal Fluid Research Grant : Rs. 1,00,000 
External    : nil 
Departmental fund   : Rs. 2,500 
 
 
12. Objectives and aims of study 
 
AIM 
To assess the incidence of deep venous thrombosis and the risk factors favouring 
its development in patients admitted to a medical ward 
 
OBJECTIVES 
1) To assess the incidence of development of deep venous thrombosis among 
patients admitted in a medical ward at a tertiary care center in South India. 
2) To evaluate the factors predisposing to the development of venous thrombosis 
in patients admitted in a medical ward. 
 
13. Summary of the proposed research scheme (250 words). 
Venous thrombosis and embolism is a common problem encountered in the 
medical wards (1) and is associated with significant contribution to health care 
cost. In 2010, the estimated heath care cost because of hospital acquired venous 
thromboembolism in the United States ranged from 6.8 to 36 billion dollars (2). 
There is a dearth of research involving venous thromboembolism in patients in 
medical wards in India. 
This study would look at the incidence of a deep venous thrombosis in a medical 
ward in a tertiary hospital in South India. It would be a physician performed 
Doppler venous ultrasonography. This study would look at the risk factors of 
developing deep venous thrombosis and the outcomes. 
The study will include all patients admitted to a medical ward during the study 
period. Patients admitted with a diagnosis of venous thrombosis or pulmonary 
embolism will be excluded. Patients on anticoagulation at the time of admission 
will also be excluded.  An informed consent will be taken from all patients 
included in the study. A day 1 clinical research form will be filled. This would 
include demographics as well as known risk factors for the development of venous 
thrombosis. It has been shown that a single repeat study that is negative after 7 
days predicts a less than 1% incidence of venous thrombus (3). Hence the Doppler 
ultrasonography will be performed on 1st, 3rd and the 7th day of hospital admission 
for included patients. The investigator and co-investigators will undergo validation 
of their skills by the department of Radiology prior to the study. The Doppler 
sonography will be done over the popliteal and femoral vessels over the lower 
limbs and the juglar and axillary regions of the upper limb. A lack of 
compressibility or a visualization of the thrombus will be considered as positive for 
venous thromboembolism (4). On day 7 or the day of discharge (whichever is 
earlier, the clinical research form will be completed with regard to the course and 
complications in the hospital. In the event of the presence of a deep venous 
thrombosis, the treating team shall be notified. 
 
14. Present Knowledge and relevant bibliography 
 
Deep vein thrombosis is the formation of clots in the peripheral veins of the body. It 
is common condition seen in hospitalized patients.  The annual incidence of deep 
venous thrombosis is estimated at 1-3 per 1000 adult population.(2) In United States 
health care costs for total deep-vein thrombosis (DVT), total hospital-acquired DVT, 
and total "preventable" DVT. Annual cost ranges were obtained in 2010 US dollars 
for total ($7.5 to $39.5 billion), hospital-acquired ($5 to $26.5 billion), and 
preventable ($2.5 to $19.5 billion) DVT costs. When the sensitivity analysis was 
applied--taking into consideration higher incidence rates and costs - annual US total, 
hospital-acquired, and "preventable" DVT costs ranged from $9.8 to $52 billion, $6.8 
to $36 billion, and $3.4 to $27 billion, respectively. (2)  Among patients admitted in a 
Medical Ward, the incidence of deep vein thrombosis is 14.9%(1) In an Indian setup, 
the incidence of DVT was found to be 2.7 per 1000 person-days of hospital 
admission. 
 
The major risk factors for development of venous thromboembolism are (1,5)  
1)   Age more than 75 years 
2)   Malignancy 
3)   Post-operative patients 
4)   Previous venous thromboembolism 
5)   Chronic respiratory disease 
6)   Heart disease 
7)   Obesity 
8)   Bed rest 
9)   NYHA class 3 and 4 heart disease 
10) Sepsis 
11) Stroke with lower limb weakness 
 
The gold standard for diagnosis of a deep venous thrombosis is a contrast venogram. 
But it is not recommended as an initial screening test, as it a invasive procedure and 
obtaining an adequate study is difficult (5) Impedence plethysmography is another 
investigational modality used for diagnosis of a deep vein thrombosis. It’s usage is 
limited by the fact that many facilities have neither the equipment nor skilled 
personnel to perform impedance plethysmography. It is the diagnostic modatily of 
choice in patients with recurrent deep vein thrombosis (5). 
 
The most commonly used investigation for the diagnosis of a deep vein thrombosis is 
a doppler ultrasound.  On an ultrasound the features suggestive of a deep vein 
thrombosis are –  
 
• Abnormal compressibility of the vein 
• Abnormal Doppler color flow 
• The presence of an echogenic band 
• Abnormal change in diameter during the Valsalva maneuver 
 
It has been shown that the lack of compressibility of a vein alone with the ultrasound 
probe is highly sensitive (>95 percent) and specific (>95 percent) for proximal vein 
thrombosis (6–8) The limitation of a compression ultrasound are – 
 
• It does not detect isolated thrombi in the iliac vein or that portion of the 
femoral vein within the adductor canal  
• The results are limited in patients with deformities or a plaster cast. 
• Serial studies need to be performed when the initial test is negative 
• Approximately 2 percent of patients with an initially negative 
ultrasound develop a positive study when retested seven days later  
• A single repeat study that is negative five to seven days after an initial 
negative study predicts a less than 1 percent likelihood of venous 
thromboembolism over months of follow-up 
• Patients with pelvic neoplasms or abscesses may demonstrate isolated 
noncompressibility of the femoral vein when thrombosis is absent 
 
Deep vein screening done at presentation and at day 7 were shown to have maximal 
accuracy in diagnosing deep venous thrombosis (6,9) It has been shown that a two point 
compression ultrasound done by emergency physicians after a 10 minute raining is as 
sensitive and aspecific to pick up a deep venous thrombosis as compared to a screening 
done by a radiologist (10) 
 
In view of the current knowledge and a dearth of data from India, it would be relevant to 
look at the incidence of deep venous thrombosis in the Medical Ward at our hospital. 
 
15. Preliminary work already done by the investigator in this problem: NIL 
 
16. List of publications of the investigator in the field: NIL 
  
17. Detailed diagrammatic Algorithm of the study  
 
 
                         
 
18. Detailed research plan: 
a. Setting: Will be done from January 2014 to April 2015 in patients admitted 
in a medical ward under Medicine unit 2 at Christian Medical College, 
Vellore, a tertiary care center in South India. 
 
b. Participants:  
Recruiting patients admitted to C 
ward 
Consent and filling CRF 
Four point doppler ultrasonography 
screening at Day 1 
Rescreening at  Day 3 and Day 7 
 Inclusion criteria: 
 Age >18 years 
 Admitted to the Medical Ward under Medicine unit 2 
 
Exclusion Criteria: 
 Refusal to give consent 
 Patients admitted with a diagnosis of DVT or pulmonary embolism 
 Patients on therapeutic anticoagulation 
 
c. Variables: 
 
Oucomes: 
DVT: Non-compressibility using a four point Doppler ultrasound at Day 1, 
Day 3 and Day 7 of hospital admission. 
Death: Death of the subject within 7 days of hospital admission 
Discharge: Discharge from the hospital within 7 days of hospital admission. 
 
Exposures: 
• Age 
• Sex 
• BMI 
• Previous history of venous thromboembolism  
• Whether on any anticoagulation 
• Malignancy 
• Stroke 
• History of trauma 
• History of surgery 
• Central venous catheters - duration 
• Dialysis ports 
• Acute respiratory distress 
• Congestive cardiac failure 
• Hypercoagulable states 
• Hormone therapy 
• COPD 
• Varicose veins 
• Mobility 
 
 
d. Data Sources/measurement:  
Data will be collected on Day 1 of hospital admission through a clinical 
research form. Variables relating to treatment and outcome will be filled on 
Day 7 of hospital admission. The presence or absence of venous 
thromboembolism will be determined by Doppler ultrasonography on Day 
1, Day 3 and Day 7 of hospitalisation. Recruitment of patients would be 
prospective and consecutive. 
 
The data would be calculated as the incidence of development of DVT in 
terms of per 1000 patient days. 
 
Prior to the commencement of the study, the skills of the principal 
investigator will be validated against a radiologist. The study will commence 
only after the validation is complete. 
 
e. Bias: Describe  
Logistical regression analysis will be done to negate the effect of 
confounders. 
 f. Sample size 
 
[{Z(1-alpha)}2xPxQ]/ [D2] 
 
Assuming incidence to be 14.9% (Mednox study), CI of 95% and error of 
margin of 5% 
1. 195.92 
 Assuming an incidence of 15% drop out/loss of data, a sample size of 220 
 shall be considered.  
 
19. Complete budget plan  
 
For FLUID research grant money cannot be allocated for travel of the investigators nor 
can job outsourcing be covered with FLUID grants. Funding out of the institution can be 
given only for the special mission hospital grant 
 
(From Fluid Research Fund, there are no grants for personnel except in a major grant   
application, funding is limited Rs. 40,000/- per year for two years for standard applications,  
Rs. 2,00,000/- per year for two years for major applications). Website link: 
http://172.16.11.136/Research/#. > Rules for Major Fluid Research Grants. Do not exceed the 
budget allocated to you. In case the budget is exceeded, the amount will have to be deducted 
from one of your departmental special funds. Stationary, printing material and paper should 
not exceed more than 20% of the allocated fluid grant.  
 
Please mention below the breakdown of budget requested: (The budgets that are drawn up 
should be comprehensive and should mention all subject in detail (For example – laboratory 
investigation should mention the specific category without generalization.)   
 
 Timeline: 2yrs – Jan 2014 – Jan 2016 
 Cost Quantity Total 
Ultrasound package (D1/3/7)  Rs. 500 220 1,20,000 
Miscellaneous Rs. 2500 - 2500 
Total   1,22,500 
 
Requesting Rs. 1,00,000/- from FLUID research grant and Rs. 12,500/- from 
Departmental funds. 
 
20. If this is an application for Fluid Research Funding, please provide name and 
account number of any other Fluid Research grant held by the PI.  
-nil- 
 
21. Informed Consent Documents (patient information sheet, investigator’s 
brochure, drug information etc and informed consent document) please submit 
all translations with the proposal.  
 
22. Inter-departmental cooperation: 
i) Department of Radiology 
The Department of Radiology is involved in the initial validation of this study 
as the primary diagnostic tool for case detection is an imaging modality, 
namely the ultrasound. 40 initial cases will enter this validation study and 
will be simultaneously screened by the principal investigator (self) and the 
radiologist. The sensitivity and specificity of the investigator’s case 
detection skills will be drawn against the radiologist, whose findings will be 
considered as the truth and the kappa value will be calculated. 
 
ii) Department of Biostatistics 
 
 
23. Signature of Principal Investigator 
 
 
24. Signature of Guide/Head of the Department/ Unit 
 
 
 
 
25. Co-Investigators’ Consent (all co-investigators have to sign this form or supply 
separate letters of consent) 
 
 
 
 
 I/We give my/our consent to be a Co-Investigator and provide my/our expertise to the 
project. I/We have approved this version of the protocol and have contributed 
substantially to its development.  
 
Name     Department   Signature  Date 
 
  
Section II 
 
APPLICATION FOR APPROVAL FROM ETHICS COMMITTEE OF THE  
INSTITUTIONAL REVIEW BOARD OF CMC VELLORE FOR  
ALL OBSERVATIONAL (CASE CONTROL, COHORT & OBSERVATIONAL) STUDIES IN HUMAN 
SUBJECTS  
 
APPLICATION FOR ETHICS APPROVAL FOR ALL INTERVENTIONAL STUDIES IN HUMAN 
PARTICIPANTS 
 
1. Please provide a brief summary of the justification, objectives and methods in lay 
language, avoiding technical terms:  
Formation of a clot in the blood vessels is known as a thrombus. The presence of 
the thrombus in the deep veins of the limbs is termed as a deep venous thrombosis. 
Deep venous thrombosis is a commonly encountered problem in hospitalized 
patients. The major dreaded consequence from deep venous thrombosis is 
pulmonary embolism (clot in the blood vessels of the lungs. Pulmonary embolism is 
the most common preventable cause of death among hospitalized patients in the 
United States.  Several studies done in the west, have established the increased 
prevalence and incidence of deep venous thrombosis in patients admitted to medical 
wards, which have now paved way to an increase in the rate of awareness and 
implementation of prophylaxis.  
The limited number of studies done on the distribution of deep venous 
thrombosis among medical patients, especially in India led to this study being 
designed to determine the frequency of distribution of deep venous thrombosis in a 
protocolized environment like the medical intensive care unit, where patients are 
already on thromboprophylaxis; and to study the risk factors unique to the 
development of deep venous thrombosis among critically ill medical patients, despite 
the prophylaxis. We hope that this study would bring to notice the interplay of 
several factors unique to hospitalized critically ill Indian medical patients, in the 
pathogenesis of deep venous thrombosis, which may inturn bring about several 
changes in our approach to the diagnosis, prophylaxis and treatment of the same; 
which would inturn benefit the community in the future. 
This study will include all patients being admitted to a Medical Ward of Christian 
Medical College, Vellore. Informed consent will be obtained from all the participants 
of the study. Each participant will be followed up for a period of one week from the 
day of admission into the intensive care unit, during which information will be 
collected on the relevant present and past history, treatment details and outcome at 
the end of the study. In addition, each will receive three sequential ultrasound scans 
by the principal investigator (self) on day 1, 3 and 7 to screen for the presence of 
deep venous thrombosis in the upper and lower limbs.  
 
2. Please describe if the study uses procedures already being performed on patients 
for diagnosis or treatment or if modified or novel procedures are to be used?  
In this study the diagnostic modality used will be a compression ultrasound. 
Several studies have proved that the compression ultrasound used by criticare and 
emergency physicians is as good as the conventional duplex ultrasound done by the 
radiologists for the detection of deep venous thrombosis. The former is also a 
simpler technique which can be easily mastered by many, and also saves a lot of time 
and cost, compared to the latter.  
Ultrasound scanning will be done on day 1, 3, and 7 from the time of admission 
into ICU on every participant. Each time, four points (2 in the upper extremity and 2 
in the lower extremity) will be screened on both sides to look for evidence of deep 
venous thrombosis. 
 
3. Please describe what benefits might be reasonably be expected by the participant 
as an outcome of participation:  
        The ultrasound testing for deep venous thrombosis is not routinely done on all 
patients in the medical ward and is done only in those with a high degree of clinical 
suspicion of deep venous thrombosis. This study will benefit every participant by 
offering them better than routine standards of care in the form of sequential ultrasound 
screening during the initial period of the ward stay, when studies have reported an 
increased occurrence of deep venous thrombosis. This study will therefore, help in early 
detection of deep venous thrombosis and therefore treatment of the same and 
prevention of its sequel in the patients. 
 
 
4. Please describe what benefits to others or new knowledge might be expected as a 
result of this study:  
This study is aimed at studying the occurrence and factors playing a role in the 
development of deep venous thrombosis in the medical patients in India, especially 
in a South Indian demographic, wherein no other study has been previously 
attempted. This study is likely to pick up the risk factors unique to the population 
under study and thereby bring about a change in our approach to diagnosis, existing 
protocol for prophylaxis and treatment of the same, resulting in guidelines more 
appropriate to the targeted group. 
 
5. Who are to be enrolled?  
All patients admitted in C Ward, Christian Medical College, Vellore, will be included in 
the study. Patients who have been admitted with a pre-existing diagnosis of deep 
venous thrombosis, those already on therapeutic anticoagulation, and those who 
refuse to be a part of the study will be excluded from the study group. 
 
6. If any vulnerable groups (e.g., pregnant women, children, economically 
disadvantaged individuals, etc) are to be enrolled, please provide a justification for 
their inclusion:  
Nil 
 
 
7. What are the potential risks to participants in this study?  
This study is not associated with any risks to the participant 
 
8. Are the risks to participants reasonable in relation to the benefits that might 
reasonably be expected as an outcome to the participant or to others, or the 
importance of the knowledge that may reasonably be expected to result? Please 
provide a detailed description of the above.  
 
This study aims to describe the occurrence of deep venous thrombosis and study the 
risk factors in medical patients in an Indian demographic. The study is designed in 
such a way that no possible risks may be arise out of it. This study, by providing 
frequent sequential ultrasound imaging for detection of deep venous thrombosis, 
attempts to elevate the standards of care offered to the patients, by paving way for 
early detection and therefore treatment of deep venous thrombosis. As most of the 
protocols in place for diagnosis and prophylaxis of deep venous thrombosis are 
adapted from studies done on western population, this study hopes to determine 
the occurrence and the predictors for development of deep venous thrombosis, 
which would be helpful in determining the need for and creation of a protocol 
endogenous to the Indian hospitalized critically ill population. 
 
9. Regarding informed consent to obtained from research participants or their legally 
authorized representative(s): 
 
a. Does the informed consent document include all the required elements?  
Yes(please find the informed consent form enclosed) 
  
b. Are the participant information sheet and the consent document in language 
understandable to participants? (PLEASE PROVIDE WITH THIS SUBMISSION 
TRANSLATIONS IN ALL LOCAL LANGUAGES ANTICIPATED TO BE USED).  
 
Yes (Please find copies of the informed consent enclosed) 
 
c. Who will obtain informed consent (PI, nurse, other?) and in what setting?  
 
Principle investigator will obtain the informed consent in C ward 
 
d. If appropriate, is there a children’s assent? If yes, please submit a copy of this 
form. 
No 
 
e. Is the EC requested to waive or alter any informed consent requirement?  
No 
 
10. Is there provision of free treatment for research related injury? If yes, who will 
provide it?  
Not applicable 
 
11. Is there provision for compensation of participants for disability or death resulting 
from research related injury. If yes, who will provide it?  
Not applicable 
 
12. Is the study covered by insurance? If yes, please provide insurance documents from an 
Indian insurance company. 
No 
 
13. In addition to the overall budget in Section I, please provide details of the following 
 
i) Justification, timing and amount of payments to study participants 
ii) Justification, timing and amount of payments to investigators/departments 
iii) Any other study related financial or in kind incentives to participants or study staff 
 
Nil 
 
14. Please describe the plan for maintaining confidentiality of study participant 
information. 
 
All details for this study will be collected through a data abstraction form by the 
principal investigator. 
 
15. Please describe the plans for monitoring the safety of participants, reporting and 
managing adverse events.  If this is an externally funded study with a Data Safety 
Monitoring Board, please provide the name and contact information of the DSMB 
chairperson. 
Not applicable 
 
16. If applicable; please provide all significant previous decisions (e.g., those leading to a 
negative decision or modified protocol) by other ECs or regulatory authorities for the 
proposed study (whether in the same location or elsewhere) and an indication of the 
modification(s) to the protocol.   
Not applicable 
 
17. If appropriate, has permission from the Drug Controller General of India been 
obtained? 
Not applicable 
 
18. If this is international collaborative research, has permission from the Health Minstry’s 
Screening Committee been obtained?  
Not applicable 
 
19. For exchange of biological material in international collaborative studies, please 
provide a MoU/ Material Transfer Agreement between the collaborating 
partners. 
Not applicable 
 
 
 
20. Declaration (to be signed by all investigators) 
By signing this form we give our consent to provide our expertise to the project. In addition: 
a. We confirm that all investigators have approved this version of the protocol and 
have contributed substantially to its development.  
b. We confirm that all potential authors are included in this protocol.  
c. We confirm that we shall submit any protocol amendments, significant deviations 
from protocols, progress reports (if required) and a final report and also 
participate in any audit of this study, if required.  
d. We confirm that we shall conduct this study in accordance with the Declaration of 
Helsinki; the ICMR Guidelines for Biomedical Research in Human Subjects 2006, 
with any subsequent amendments; and all applicable laws of the land.  
e. We also agree to submit for publication to a peer reviewed journal the complete 
results of this study within two years of completion of this study.  
f. We declare that we have no conflicts of interest that may affect the conduct or 
reporting of this study (OR) we declare the following conflicts of interest below. 
g. We are aware of the institution’s policies regarding scientific misconduct 
(Falsification/fabrication/plagiarism) and agree to abide by them. 
 
 
 
 
 
2. Signature of Principal Investigator 
 
 
 
3. Signature of Guide/Head of the Department/ Unit 
 
Annexure 4 – Definitions 
 Well’s score 
 Clinically suspected DVT — 3.0 points 
 Alternative diagnosis is less likely than PE — 3.0 points 
 Tachycardia (heart rate > 100) — 1.5 points 
 Immobilization (≥ 3d)/surgery in previous four weeks — 1.5 points 
 History of DVT or PE — 1.5 points 
 Hemoptysis — 1.0 points 
 Malignancy (with treatment within 6 months) or palliative — 1.0 points 
 
 
 
 
 
 
 
 
 
 
 
